Cargando…

Nifedipine plus candesartan combination increases blood pressure control regardless of race and improves the side effect profile: DISTINCT randomized trial results

OBJECTIVES: DISTINCT (reDefining Intervention with Studies Testing Innovative Nifedipine GITS – Candesartan Therapy) aimed to determine the dose–response and tolerability of nifedipine GITS and/or candesartan cilexetil therapy in participants with hypertension. METHODS: In this 8-week, multinational...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kjeldsen, Sverre E., Sica, Domenic, Haller, Hermann, Cha, Gloria, Gil-Extremera, Blas, Harvey, Peter, Heyvaert, Frank, Lewin, Andrew J., Villa, Giuseppe, Mancia, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2014
Materias:	ORIGINAL PAPERS: Therapeutic aspects
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227617/ https://www.ncbi.nlm.nih.gov/pubmed/25144296 http://dx.doi.org/10.1097/HJH.0000000000000331

Ejemplares similares

Nifedipine GITS/Candesartan Combination Therapy Lowers Blood Pressure Across Different Baseline Systolic and Diastolic Blood Pressure Categories: DISTINCT Study Subanalyses
por: Kjeldsen, Sverre E., et al.
Publicado: (2016)

Blood pressure-lowering effects of nifedipine/candesartan combinations in high-risk individuals: subgroup analysis of the DISTINCT randomised trial
por: Mancia, G, et al.
Publicado: (2017)

Effects on office and home blood pressure of the lercanidipine-enalapril combination in patients with Stage 2 hypertension: a European randomized, controlled clinical trial
por: Mancia, Giuseppe, et al.
Publicado: (2014)

A randomized titrate-to-target study comparing fixed-dose combinations of azilsartan medoxomil and chlorthalidone with olmesartan and hydrochlorothiazide in stage-2 systolic hypertension
por: Cushman, William C., et al.
Publicado: (2018)

Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report
por: Dell’Oro, Raffaella, et al.
Publicado: (2017)

Glycosuria medicated with ipragliflozin and nifedipine or ipragliflozin and candesartan: a case report
por: Okada, Shuichi, et al.
Publicado: (2014)

Nifedipine improves blood flow and oxygen supply, but not steady-state oxygenation of tumours in perfusion pressure-controlled isolated limb perfusion
por: Thews, O, et al.
Publicado: (2002)

In vitro inhibition of breast cancer spheroid-induced lymphendothelial defects resembling intravasation into the lymphatic vasculature by acetohexamide, isoxsuprine, nifedipin and proadifen
por: Kretschy, N, et al.
Publicado: (2013)

Pharmacogenetics of antipsychotic-induced side effects
por: Lencz, Todd, et al.
Publicado: (2009)

Psychiatric side effects of medications prescribed in internal medicine
por: Casagrande Tango, Rodrigo
Publicado: (2003)

Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy
por: Schumacher, Christoph D., et al.
Publicado: (2013)

More rigorous protocol adherence to intensive structured management improves blood pressure control in primary care: results from the Valsartan Intensified Primary carE Reduction of Blood Pressure study
por: Stewart, Simon, et al.
Publicado: (2014)

Changes in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012
por: Sengul, Sule, et al.
Publicado: (2016)

Evaluation of renal nerve morphological changes and norepinephrine levels following treatment with novel bipolar radiofrequency delivery systems in a porcine model
por: Cohen-Mazor, Meital, et al.
Publicado: (2014)

Time of administration important? Morning versus evening dosing of valsartan
por: Zappe, Dion H., et al.
Publicado: (2015)

Long-term effect of specific treatment of primary aldosteronism on carotid intima–media thickness
por: Holaj, Robert, et al.
Publicado: (2015)

Preferable effects of olmesartan/calcium channel blocker to olmesartan/diuretic on blood pressure variability in very elderly hypertension: COLM study subanalysis
por: Rakugi, Hiromi, et al.
Publicado: (2015)

Effects of risk assessment and management programme for hypertension on clinical outcomes and cardiovascular disease risks after 12 months: a population-based matched cohort study
por: Yu, Esther Y.T., et al.
Publicado: (2017)

Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial
por: Mathiassen, Ole N., et al.
Publicado: (2016)

Management of hypertension and diabetes mellitus by cardiovascular and endocrine physicians: a China registry
por: Song, Jie, et al.
Publicado: (2016)

Effects of azilsartan medoxomil compared with olmesartan and valsartan on ambulatory and clinic blood pressure in patients with type 2 diabetes and prediabetes
por: White, William B., et al.
Publicado: (2016)

Effects of a nationwide strategy to reduce salt intake in Samoa
por: Trieu, Kathy, et al.
Publicado: (2018)

Patients’ and healthcare providers’ perceptions and practices regarding hypertension, pharmacy-based care, and mHealth in Lagos, Nigeria: a mixed methods study
por: Cremers, Anne L., et al.
Publicado: (2019)

Cost-effectiveness of nitrendipine and hydrochlorothiazide or metoprolol to treat hypertension in rural community health centers in China
por: Wang, Zengwu, et al.
Publicado: (2017)

Low medication adherence is associated with decline in health-related quality of life: results of a longitudinal analysis among older women and men with hypertension
por: Peacock, Erin, et al.
Publicado: (2021)

Differences in patient and physician perspectives on pharmaceutical therapy and renal denervation for the management of hypertension
por: Schmieder, Roland E., et al.
Publicado: (2021)

A novel angiotensin II peptide vaccine without an adjuvant in mice
por: Nakamaru, Ryo, et al.
Publicado: (2021)

Health-care costs of losartan and candesartan in the primary treatment of hypertension
por: Henriksson, M, et al.
Publicado: (2011)

Late outcomes of renal denervation are more favourable than early ones: facts or fancies?
por: Persu, Alexandre, et al.
Publicado: (2023)

Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension
por: Kjeldsen, S E, et al.
Publicado: (2010)

EARLY PREDICTION OF UNEXPECTED LATENT SHOCK IN THE EMERGENCY DEPARTMENT USING VITAL SIGNS
por: Chang, Hansol, et al.
Publicado: (2023)

Candesartan in heart failure
por: Ripley, Toni L, et al.
Publicado: (2006)

Cost Effectiveness Analysis of Candesartan Therapy in Comparison to Candesartan-Amlodipine Therapy on Hypertensive Outpatients
por: Baroroh, Faridah, et al.
Publicado: (2019)

Microalbuminuria and sRAGE in High-Risk Hypertensive Patients Treated with Nifedipine/Telmisartan Combination Treatment: A Substudy of TALENT
por: Falcone, Colomba, et al.
Publicado: (2012)

Baroreflex Sensitivity and Blood Pressure Variability can Help in Understanding the Different Response to Therapy During Acute Phase of Septic Shock
por: Carrara, Marta, et al.
Publicado: (2018)

Tracking the Identity of Lister's Pneumococcal Groups T and V (Danish Types 45 and 46)
por: Austrian, Robert
Publicado: (1982)

John R. Paul and the Definition of Preventive Medicine
por: Viseltear, Arthur J.
Publicado: (1982)

History of Epidemiological Aspects of Yellow Fever
por: Downs, Wilbur G.
Publicado: (1982)

Are all antidepressants alike?
por: Schulz, Pierre
Publicado: (1999)

Treatment of depression in late life
por: Schneider, Lon S.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_1t2l02nmt7pqe1u0rsim4h5uig